Jasper Therapeutics Inc
NASDAQ:JSPR
Income Statement
Earnings Waterfall
Jasper Therapeutics Inc
Income Statement
Jasper Therapeutics Inc
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(27)
|
(31)
|
(37)
|
(43)
|
(47)
|
(50)
|
(51)
|
(52)
|
(58)
|
(65)
|
(69)
|
(70)
|
(68)
|
(69)
|
(76)
|
(83)
|
(94)
|
(93)
|
|
| Selling, General & Administrative |
(8)
|
(9)
|
(11)
|
(14)
|
(15)
|
(16)
|
(17)
|
(16)
|
(17)
|
(18)
|
(17)
|
(18)
|
(18)
|
(19)
|
(20)
|
(21)
|
(22)
|
(22)
|
|
| Research & Development |
(19)
|
(21)
|
(25)
|
(29)
|
(32)
|
(34)
|
(35)
|
(36)
|
(41)
|
(47)
|
(52)
|
(52)
|
(50)
|
(50)
|
(56)
|
(62)
|
(72)
|
(72)
|
|
| Operating Income |
(27)
N/A
|
(31)
-15%
|
(37)
-20%
|
(43)
-18%
|
(47)
-8%
|
(50)
-6%
|
(51)
-3%
|
(52)
-2%
|
(58)
-11%
|
(65)
-11%
|
(69)
-6%
|
(70)
-2%
|
(68)
+3%
|
(69)
-1%
|
(76)
-11%
|
(83)
-9%
|
(94)
-13%
|
(93)
+1%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(12)
|
(8)
|
(4)
|
0
|
(0)
|
0
|
0
|
1
|
3
|
4
|
5
|
5
|
6
|
5
|
5
|
4
|
3
|
2
|
|
| Total Other Income |
0
|
7
|
10
|
20
|
22
|
16
|
14
|
2
|
0
|
(0)
|
(1)
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(39)
N/A
|
(32)
+19%
|
(31)
+3%
|
(23)
+25%
|
(25)
-9%
|
(34)
-34%
|
(38)
-12%
|
(50)
-32%
|
(55)
-11%
|
(61)
-10%
|
(64)
-6%
|
(64)
+1%
|
(62)
+2%
|
(64)
-2%
|
(71)
-12%
|
(79)
-11%
|
(91)
-15%
|
(91)
0%
|
|
| Net Income | |||||||||||||||||||
| Income from Continuing Operations |
(39)
|
(32)
|
(31)
|
(23)
|
(25)
|
(34)
|
(38)
|
(50)
|
(55)
|
(61)
|
(64)
|
(64)
|
(62)
|
(64)
|
(71)
|
(79)
|
(91)
|
(91)
|
|
| Net Income (Common) |
(39)
N/A
|
(32)
+19%
|
(31)
+3%
|
(23)
+25%
|
(25)
-9%
|
(34)
-34%
|
(38)
-12%
|
(50)
-32%
|
(55)
-11%
|
(61)
-10%
|
(64)
-6%
|
(64)
+1%
|
(62)
+2%
|
(64)
-2%
|
(71)
-12%
|
(79)
-11%
|
(91)
-15%
|
(91)
0%
|
|
| EPS (Diluted) |
-10.3
N/A
|
-8.34
+19%
|
-8.09
+3%
|
-6.35
+22%
|
-6.89
-9%
|
-9.16
-33%
|
-10.33
-13%
|
-5.64
+45%
|
-5.07
+10%
|
-5.56
-10%
|
-6.18
-11%
|
-4.79
+22%
|
-4.16
+13%
|
-4.23
-2%
|
-4.89
-16%
|
-5.25
-7%
|
-5.92
-13%
|
-5.47
+8%
|
|